interleukin-12-Fc fusion protein DF6002
Term · Oncology and biomedicine · MLC-T-ONC-014478
A fusion protein composed of human Interleukin-12 (IL-12) fused to a Fc fragment, with potential immunomodulatory and antineoplastic activities. Although the exact mechanism of action has not been completely characterized, upon administration, the IL-12 moiety binds to the IL-12 receptor. This may activate the immune system by promoting the secretion of interferon-gamma, activating natural killer cells (NKs), and inducing cytotoxic T-lymphocyte (CTL) responses, which may result in both decreased tumor cell proliferation and enhanced immune-mediated destruction of tumor cells.
| Identifier | MLC-T-ONC-014478 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | IL12-Fc fusion protein DF6002 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014478",
"term": "interleukin-12-Fc fusion protein DF6002",
"field": "Oncology and biomedicine",
"definition": "A fusion protein composed of human Interleukin-12 (IL-12) fused to a Fc fragment, with potential immunomodulatory and antineoplastic activities. Although the exact mechanism of action has not been completely characterized, upon administration, the IL-12 moiety binds to the IL-12 receptor. This may activate the immune system by promoting the secretion of interferon-gamma, activating natural killer cells (NKs), and inducing cytotoxic T-lymphocyte (CTL) responses, which may result in both decreased tumor cell proliferation and enhanced immune-mediated destruction of tumor cells.",
"synonyms": [
"IL12-Fc fusion protein DF6002"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/interleukin-12-fc-fusion-protein-df6002/"
}
Record 9,335 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.